Date of Conferral

5-3-2024

Date of Award

May 2024

Degree

Ph.D.

School

Public Health

Advisor

Aaron Mendelsohn

Abstract

Asthma is a chronic lung disease that has significant public health and economic impact. Nonadherence to asthma medications can lead to poor treatment response and poor asthma outcomes. Digital health technologies have been shown to improve asthma medication adherence as well as asthma outcomes. The purpose of this quantitative research study was to examine the relationship between patient characteristics and mobile app engagement and the relationship between patient engagement with a digital inhaler app and asthma control in adult patients with uncontrolled asthma who were assigned to use a digitally enabled asthma medication and accompanying app for asthma therapy. Several theoretical models, including the technology acceptance model and self-determination theory, formed the conceptual framework for the study. Data were used from the CONNECT2 (2021-2022) randomized control study designed to evaluate the impact of the digital inhaler technology on asthma control. The results of logistic regression analyses showed that Whites had 3.63 greater odds of engaging with the app than non-Whites and there was a 1.024 increase in the odds of engaging with the app for every 1-year increase in age. There was a statistically significant relationship between app engagement and asthma control at the end of the primary study. Implications for positive social change include a better understanding of the association between patients engaging with digital inhaler technologies and their asthma control that offers objective information to healthcare professionals, payers, and policymakers on whether patient engagement can help patients achieve improved asthma outcomes.

Available for download on Saturday, May 03, 2025

Included in

Epidemiology Commons

Share

 
COinS